Shares of The Advisory Board Company (NASDAQ:ABCO) have earned an average rating of “Hold” from the seventeen research firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $47.08.

ABCO has been the topic of a number of recent research reports. Zacks Investment Research lowered shares of The Advisory Board Company from a “buy” rating to a “hold” rating in a report on Tuesday, April 25th. Robert W. Baird raised shares of The Advisory Board Company from a “neutral” rating to an “outperform” rating and upped their price objective for the company from $50.00 to $53.00 in a research note on Monday, March 27th. TheStreet downgraded shares of The Advisory Board Company from a “b-” rating to a “c” rating in a research note on Friday, May 5th. SunTrust Banks, Inc. downgraded shares of The Advisory Board Company from a “buy” rating to a “hold” rating and set a $45.00 price objective for the company. in a research note on Friday, March 10th. Finally, Credit Suisse Group upped their price objective on shares of The Advisory Board Company from $54.00 to $55.00 and gave the company an “outperform” rating in a research note on Friday, May 5th.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/06/19/the-advisory-board-company-abco-given-consensus-recommendation-of-hold-by-brokerages.html.

The Advisory Board Company (NASDAQ ABCO) traded up 0.87% during midday trading on Monday, reaching $51.95. 23,262 shares of the company traded hands. The Advisory Board Company has a 12 month low of $24.85 and a 12 month high of $54.50. The company’s 50-day moving average price is $51.32 and its 200 day moving average price is $44.50. The firm has a market capitalization of $2.11 billion, a PE ratio of 21.05 and a beta of 1.30.

The Advisory Board Company (NASDAQ:ABCO) last released its earnings results on Thursday, May 4th. The business services provider reported $0.38 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.26 by $0.12. The company had revenue of $194.50 million for the quarter, compared to analyst estimates of $188.43 million. The Advisory Board Company had a net margin of 12.78% and a return on equity of 14.48%. The firm’s quarterly revenue was down 3.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.44 EPS. On average, equities analysts anticipate that The Advisory Board Company will post $1.97 earnings per share for the current year.

In related news, insider Cormac F. Miller sold 750 shares of the stock in a transaction that occurred on Wednesday, April 19th. The shares were sold at an average price of $47.37, for a total transaction of $35,527.50. Following the completion of the sale, the insider now owns 21,360 shares of the company’s stock, valued at approximately $1,011,823.20. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Robert W. Musslewhite sold 11,000 shares of the stock in a transaction that occurred on Monday, April 10th. The stock was sold at an average price of $47.48, for a total transaction of $522,280.00. Following the sale, the chief executive officer now directly owns 262,587 shares of the company’s stock, valued at approximately $12,467,630.76. The disclosure for this sale can be found here. In the last three months, insiders have sold 42,946 shares of company stock valued at $2,027,677. Corporate insiders own 4.70% of the company’s stock.

A number of hedge funds have recently bought and sold shares of the company. Howard Hughes Medical Institute acquired a new stake in The Advisory Board Company during the first quarter worth about $158,000. Russell Investments Group Ltd. acquired a new stake in The Advisory Board Company during the fourth quarter worth about $3,479,000. Two Sigma Investments LP increased its stake in The Advisory Board Company by 938.7% in the fourth quarter. Two Sigma Investments LP now owns 76,882 shares of the business services provider’s stock worth $2,556,000 after buying an additional 69,480 shares during the period. Corsair Capital Management L.P. acquired a new stake in The Advisory Board Company during the first quarter worth about $2,783,000. Finally, Teachers Advisors LLC increased its stake in The Advisory Board Company by 4.7% in the fourth quarter. Teachers Advisors LLC now owns 72,192 shares of the business services provider’s stock worth $2,400,000 after buying an additional 3,219 shares during the period.

About The Advisory Board Company

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.

Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with MarketBeat.com's FREE daily email newsletter.